| 1.43 -0.005 (-0.35%) | 10-21 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Sharecare, Inc. functions as a provider of digital healthcare platforms. Its central platform acts as a nexus, uniting a diverse ecosystem of individuals, patients, healthcare providers, employers, health insurance companies, government agencies, and local communities, all with the goal of fostering improved health outcomes for both individuals and the wider population. The company delivers enterprise-grade solutions via a Software-as-a-Service (SaaS) framework, empowering corporate clients to effectively communicate with, inspire, and oversee the well-being of their constituents, while also monitoring their collective advancement. Additionally, Sharecare offers a comprehensive array of data-centric and informational tools, alongside specialized life sciences offerings. These provide users with customized information, structured programs, and essential resources tailored to boost their overall health and vitality. A key offering is RealAge, its proprietary health assessment platform. This tool evaluates users' lifestyles and pre-existing medical conditions, subsequently yielding a quantifiable measure of their physical health. Furthermore, the company supplies medical institutions with secure, automated information release, auditing, and strategic business consulting services, all designed to optimize and simplify the management of medical records. Sharecare's services are distributed through a dual approach: a dedicated direct sales force complemented by strategic partnerships. Established in 2009, Sharecare's corporate headquarters are situated in Atlanta, Georgia.
Mon, 01 Jul 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sat, 15 Jun 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sharecare, Inc. - SHCR - PR Newswire
Fri, 17 May 2024
Levi & Korsinsky Notifies Sharecare, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SHCR - GlobeNewswire
Fri, 10 May 2024
Sharecare Inc (SHCR) Q1 2024 Earnings: Revenue Decline Amid Strategic Review - Yahoo Finance
Fri, 24 Mar 2023
Rajeev Ronanki Net Worth (2026) - GuruFocus
Mon, 06 Mar 2023
Claritas Sharecare F3 Llc Net Worth (2026) - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|